|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
����,�������� |
|
Ƥ��,��Ӧ�� |
|
Ƥ��,�Ӵ��� |
| ��������������� | |
|
���� |
|
����÷ |
|
��־ǿ |
| PubMed | |
|
Article by |
|
Article by |
|
Article by |
��������������Ƥ����̬��Ӧ
����, ����÷, ��־ǿ
�й�ҽѧ��ѧԺ���й�Э��ҽ�ƴ�ѧƤ�����о��� �Ͼ� 210042
��������ͨ��������Ӧ�����Ϻ�����,����Th1/Th2ϸ������ͬʱ�鵼Ƥ����̬��Ӧ��������������������Ƥ����̬��Ӧ�е�����ѧ����,��������������Th1/Th2ϸ������ƽ��֮��Ĺ���,�ص�������Ƥ����̬��Ӧ�йص�8��������������,����������������Ӧ��Ƥ����Ӧ�ԽӴ���Ƥ���е����ü����������е����á�
[2] Reid S,Ritchie A,Boring L,et al.Enhanced myeloid progenitor cell cycling and apoptosis in mice lacking the chemokine receptor,CCR2.Blood,1999,93(5):1524-1533.
[3] Bonecchi R,Facchetti F,Dusi S,et al.Induction of functional IL-8 receptors by IL-4 and IL-13 in human monocytes.J Immunol,2000,164(7):3862-3869.
[4] Tensen CP,Flier J,Van Der Raaij-Helmer EM,et al.Human IP-9:A keratinocyte-derived high affinity CXC-chemokine ligand for the IP-10/Mig receptor(CXCR3).J Invest Dermatol,1999,112(5):716-722.
[5] Flier J,Boorsma DM,van Beek PJ,et al.Differential expression of CXCR3 targeting chemokines CXCL10,CXCL9,and CXCL11 in different types of skin inflammation.J Pathol,2001,194(4):398-405.
[6] Albanesi C,Scarponi C,Sebastiani S,et al.IL-4 enhances keratinocyte expression of CXCR3 agonistic chemokines.J Immunol,2000,165(3):1395-1402.
[7] Banwell ME,Tolley NS,Williams TJ,et al.Regulation of human eotaxin-3/CCL26 expression:modulation by cytokines and glucocorticoids.Cytokine,2002,17(6):317-323.
[8] Varona R,Villares R,Carramolino L,et al.CCR6-deficient mice have impaired leukocyte homeostasis and altered contact hypersensitivity and delayed-type hypersensitivity responses.J Clin Invest,2001,107(6):R37-45.
[9] Nakayama T,Fujisawa R,Yamada H,et al.Inducible expression of a CC chemokine liver-and activation-regulated chemokine(LARC)/macrophage inflammatory protein(MIP)-3 alpha/CCL20 by epidermal keratinocytes and its role in atopic dermatitis.Int Immunol,2001,13(1):95-103.
[10] Sebastiani S,Albanesi C,De PO,et al.The role of chemokines in allergic contact dermatitis.Arch Dermatol Res,2002,293(11):552-559.
[11] Sebastiani S,Allavena P,Albanesi C,et al.Chemokine receptor expression and function in CD4+ T lymphocytes with regulatory activity.J Immunol,2001,166(2):996-1002.
[12] Homey B,Wang W,Soto H,et al.Cutting edge:the orphan chemokine receptor G protein-coupled receptor-2(GPR-2,CCR10) binds the skin-associated chemokine CCL27(CTACK/ALP/ILC).J Immunol,2000,164(7):3465-3470.
[13] Kulke R,Bornscheuer E,Schluter C,et al.The CXC receptor 2 is overexpressed in psoriatic epidermis.J Invest Dermatol,1998,110(1):90-94.
[14] Cosmi L,Annunziato F,Galli MIG,et al.CRTH2 is the most reliable marker for the detection of circulating human type 2 Th and type 2 T cytotoxic cells in health and disease.Eur J Immunol,2000,30(10):2972-2979.
[15] Nakatani T,Kaburagi Y,Shimada Y,et al.CCR4 memory CD4+ T lymphocytes are increased in peripheral blood and lesional skin from patients with atopic dermatitis.J Allergy Clin Immunol,2001,107(2):353-358.
[16] Ying S,Robinson DS,Meng Q,et al.C-C chemokines in allergen-induced late-phase cutaneous responses in atopic subjects:association of eotaxin with early 6-hour eosinophils,and of eotaxin-2 and monocyte chemoattractant protein-4 with the later 24-hour tissue eosinophilia,and relationship to basophils and other C-C chemokines(monocyte chemoattractant protein-3 and RANTES).J Immunol,1999,163(7):3976-3984.
[17] Yawalkar N,Uguccioni M,Scharer J,et al.Enhanced expression of eotaxin and CCR3 in atopic dermatitis.J Invest Dermatol,1999,113(1):43-48.
[18] Wakugawa M,Nakamura K,Kakinuma T,et al.CC chemokine receptor 4 expression on peripheral blood CD4+ T cells reflects disease activity of atopic dermatitis.J Invest Dermatol,2001,117(2):188-196.
[19] Kakinuma T,Nakamura K,Wakugawa M,et al.Thymus and activation-regulated chemokine in atopic dermatitis:Serum thymus and activation-regulated chemokine level is closely related with disease activity.J Allergy Clin Immunol,2001,107(3):535-541.
[20] Uchida T,Suto H,Ra C,et al.Preferential expression of T(h)2-type chemokine and its receptor in atopic dermatitis.Int Immunol,2002,14(12):1431-1438.
[21] Fujisawa T,Fujisawa R,Kato Y,et al.Presence of high contents of thymus and activation-regulated chemokine in platelets and elevated plasma levels of thymus and activation-regulated chemokine and macrophage-derived chemokine in patients with atopic dermatitis.J Allergy Clin Immunol,2002,110(1):139-146.
[22] Tokuriki A,Seo N,Ito T,et al.Dominant expression of CXCR3 is associated with induced expression of IP-10 at hapten-challenged sites of murine contact hypersensitivity:a possible role for interferon-gamma-producing CD8(+) T cells in IP-10 expression.J Dermatol Sci,2002,28(3):234-241.
[23] Martin AP,Ortiz S,Cabalier ME,et al.Vascular endothelium express CS-1 fibronectin in allergic contact dermatitis.J Cutan Pathol,2002,29(6):347-353.
[24] Flier J,Boorsma DM,Bruynzeel DP,et al.The CXCR3 activating chemokines IP-10,Mig,and IP-9 are expressed in allergic but not in irritant patch test reactions.J Invest Dermatol,1999,113(4):574-578.
[25] Sebastiani S,Albanesi C,Nasorri F,et al.Nickel-specific CD4(+) and CD8(+) T cells display distinct migratory responses to chemokines produced during allergic contact dermatitis.J Invest Dermatol,2002,118(6):1052-1058.